GlassScriptPhysician profile
David Cooper
NPI 1619949716
$2,631.60
in general payments reported to CMS, 2019-2025
30 companies · $433 in 2025
The $433 reported for 2025 was more than what 76% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $210 · 2021: $344 · 2022: $578 · 2023: $332 · 2024: $281 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $913.66 | 2021-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Astrazeneca Pharmaceuticals LP | $382.25 | 2019-2025 | Fasenra, Tezspire |
| Covis Pharma Gmbh | $188.40 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $169.43 | 2019-2025 | Trikafta |
| Genzyme Corporation | $163.11 | 2019-2023 | |
| Baxter Healthcare | $86.79 | 2022-2025 | Hillrom - Monarch Airway Clearance System |
| Glaxosmithkline, LLC. | $83.60 | 2019-2024 | Nucala |
| Abbvie INC. | $66.55 | 2019-2021 | |
| Gilead Sciences, INC. | $66.21 | 2019 | |
| Chiesi USA, INC. | $60.34 | 2020-2021 | |
| Alcresta Therapeutics, INC. | $59.81 | 2019 | |
| Jazz Pharmaceuticals INC. | $40.95 | 2019-2021 | |
| Amgen INC. | $30.56 | 2022-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.43 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $28.53 | 2022-2024 | Dupixent |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $26.50 | 2019-2020 | |
| Biogen, INC. | $24.99 | 2020 | |
| Phadia US INC. | $24.50 | 2024 | Immunocap |
| Aimmune Therapeutics, INC. | $19.38 | 2025 | Zenpep |
| Electromed, INC. | $19.08 | 2021 | |
| Azurity Pharmaceuticals, INC. | $17.68 | 2025 | Alvesco |
| Aero US INC | $16.90 | 2025 | Aerogen Solo Nebulizer System, Aerogen Usb Controller System, Aerogen Solo; Aerogen Ultra |
| Sanofi Pasteur INC. | $16.31 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.23 | 2019 | |
| Insmed, INC. | $15.00 | 2019 | |
| Opko Pharmaceuticals, LLC | $14.12 | 2019 | |
| Harmony Biosciences LLC | $13.74 | 2020 | |
| Alk-Abello, INC | $13.67 | 2022 | |
| 3b Medical, INC. | $13.65 | 2025 | Luna |
| Allergan, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.